{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:24:50Z","timestamp":1770269090562,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12020-016-1042-2","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:49:28Z","timestamp":1469526568000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience"],"prefix":"10.1007","volume":"54","author":[{"given":"Christine G.","family":"Yedinak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Cetas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alp","family":"Ozpinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aclan","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"1042_CR1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas: a systematic review. Cancer 101, 613\u2013619 (2004)","journal-title":"Cancer"},{"key":"1042_CR2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jocn.2008.11.001","volume":"16","author":"CG Patil","year":"2009","unstructured":"C.G. Patil, M. Hayden, L. Katznelson, S.D. Chang, Non-surgical management of hormone-secreting pituitary tumors. J. Clin. Neurosci. 16, 985\u2013993 (2009)","journal-title":"J. Clin. Neurosci."},{"key":"1042_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte, J.A. Wass, S. Endocrine, Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 273\u2013288 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"A. Ciccarelli, A.F. Daly, A. Beckers, The epidemiology of prolactinomas. Pituitary 8, 3\u20136 (2005)","journal-title":"Pituitary"},{"key":"1042_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. (Oxf.) 72, 377\u2013382 (2010)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1042_CR6","doi-asserted-by":"crossref","unstructured":"M.P. Gillam, M.E. Molitch, in Pituitary, ed. S. Melmed (Elsevier, Philadelphia, 2011), pp. 475\u2013531","DOI":"10.1016\/B978-0-12-380926-1.10015-X"},{"key":"1042_CR7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","volume":"96","author":"MM Fernandez-Balsells","year":"2011","unstructured":"M.M. Fernandez-Balsells, M.H. Murad, A. Barwise, J.F. Gallegos-Orozco, A. Paul, M.A. Lane, J.F. Lampropulos, I. Natividad, L. Perestelo-Perez, P.G. Ponce de Leon-Lovaton, P.J. Erwin, J. Carey, V.M. Montori, Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 96, 905\u2013912 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"M.P. Gillam, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27, 485\u2013534 (2006)","journal-title":"Endocr. Rev."},{"key":"1042_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","volume":"60","author":"ME Molitch","year":"1985","unstructured":"M.E. Molitch, R.L. Elton, R.E. Blackwell, B. Caldwell, R.J. Chang, R. Jaffe, G. Joplin, R.J. Robbins, J. Tyson, M.O. Thorner, Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J. Clin. Endocrinol. Metab. 60, 698\u2013705 (1985)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","volume":"23","author":"A Colao","year":"2009","unstructured":"A. Colao, The prolactinoma. Best Pract. Res. Clin. Endocrinol. Metab. 23, 575\u2013596 (2009)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1042_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cen.12124","volume":"79","author":"N Karavitaki","year":"2013","unstructured":"N. Karavitaki, R. Dobrescu, J.V. Byrne, A.B. Grossman, J.A. Wass, Does hypopituitarism recover when macroprolactinomas are treated with cabergoline? Clin. Endocrinol. (Oxf.) 79, 217\u2013223 (2013)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1042_CR12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-14-0990","volume":"172","author":"E Delgrange","year":"2015","unstructured":"E. Delgrange, A. Vasiljevic, A. Wierinckx, P. Francois, E. Jouanneau, G. Raverot, J. Trouillas, Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. Eur. J. Endocrinol. 172, 791\u2013801 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"1042_CR13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-09-0997","volume":"162","author":"C Berg","year":"2010","unstructured":"C. Berg, T. Meinel, H. Lahner, K. Mann, S. Petersenn, Recovery of pituitary function in the late-postoperative phase after pituitary surgery: results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgery. Eur. J. Endocrinol. 162, 853\u2013859 (2010)","journal-title":"Eur. J. Endocrinol."},{"key":"1042_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1025377816769","volume":"5","author":"L Sibal","year":"2002","unstructured":"L. Sibal, P. Ugwu, P. Kendall-Taylor, S.G. Ball, R.A. James, S.H. Pearce, K. Hall, R. Quinton, Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary 5, 243\u2013246 (2002)","journal-title":"Pituitary"},{"key":"1042_CR15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11102-015-0643-8","volume":"18","author":"C Yedinak","year":"2015","unstructured":"C. Yedinak, N. Hameed, M. Gassner, J. Brzana, S. McCartney, M. Fleseriu, Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study. Pituitary 18, 701\u2013709 (2015)","journal-title":"Pituitary"},{"key":"1042_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000430815","volume":"102","author":"G Carosi","year":"2015","unstructured":"G. Carosi, E. Malchiodi, E. Ferrante, E. Sala, E. Verrua, E. Profka, C. Giavoli, M. Filopanti, P. Beck-Peccoz, A. Spada, G. Mantovani, Hypothalamic-pituitary axis in non-functioning pituitary adenomas: focus on the prevalence of isolated central hypoadrenalism. Neuroendocrinology 102, 267\u2013273 (2015)","journal-title":"Neuroendocrinology"},{"key":"1042_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3171\/jns.1984.61.3.0577","volume":"61","author":"AT Nelson Jr.","year":"1984","unstructured":"A.T. Nelson Jr., H.S. Tucker Jr., D.P. Becker, Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas. J. Neurosurg. 61, 577\u2013580 (1984)","journal-title":"J. Neurosurg."},{"key":"1042_CR18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1507\/endocrj.42.421","volume":"42","author":"A Tominaga","year":"1995","unstructured":"A. Tominaga, T. Uozumi, K. Arita, K. Kurisu, T. Yano, T. Hirohata, Anterior pituitary function in patients with nonfunctioning pituitary adenoma: results of longitudinal follow-up. Endocr. J. 42, 421\u2013427 (1995)","journal-title":"Endocr. J."},{"key":"1042_CR19","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","volume":"84","author":"SM Webb","year":"1999","unstructured":"S.M. Webb, M. Rigla, A. Wagner, B. Oliver, F. Bartumeus, Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J. Clin. Endocrinol. Metab. 84, 3696\u20133700 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4158\/EP09153.OR","volume":"16","author":"M Fleseriu","year":"2010","unstructured":"M. Fleseriu, M. Gassner, C. Yedinak, L. Chicea, J.B. Delashaw Jr., D.L. Loriaux, Normal hypothalamic-pituitary-adrenal axis by high-dose cosyntropin testing in patients with abnormal response to low-dose cosyntropin stimulation: a retrospective review. Endocr. Pract. 16, 64\u201370 (2010)","journal-title":"Endocr. Pract."},{"key":"1042_CR21","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2008-0710","volume":"93","author":"R Kazlauskaite","year":"2008","unstructured":"R. Kazlauskaite, A.T. Evans, C.V. Villabona, T.A. Abdu, B. Ambrosi, A.B. Atkinson, C.H. Choi, R.N. Clayton, C.H. Courtney, E.N. Gonc, M. Maghnie, S.R. Rose, S.G. Soule, K. Tordjman, Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 4245\u20134253 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12020-014-0281-3","volume":"47","author":"R Salvatori","year":"2014","unstructured":"R. Salvatori, Surgical treatment of microprolactinomas: pros. Endocrine 47, 725\u2013729 (2014)","journal-title":"Endocrine"},{"key":"1042_CR23","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","volume":"98","author":"P Burman","year":"2013","unstructured":"P. Burman, A.F. Mattsson, G. Johannsson, C. Hoybye, H. Holmer, P. Dahlqvist, K. Berinder, B.E. Engstrom, B. Ekman, E.M. Erfurth, J. Svensson, J. Wahlberg, F.A. Karlsson, Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J. Clin. Endocrinol. Metab. 98, 1466\u20131475 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","volume":"100","author":"JM Pappachan","year":"2015","unstructured":"J.M. Pappachan, D. Raskauskiene, V.R. Kutty, R.N. Clayton, Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J. Clin. Endocrinol. Metab. 100, 1405\u20131411 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR25","doi-asserted-by":"crossref","unstructured":"G. Johannsson, Improving glucocorticoid replacement in patients with adrenal insufficiency. Endocrine (2016)","DOI":"10.1007\/s12020-016-0929-2"},{"key":"1042_CR26","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"M. Sherlock, R.C. Reulen, A.A. Alonso, J. Ayuk, R.N. Clayton, M.C. Sheppard, M.M. Hawkins, A.S. Bates, P.M. Stewart, ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J. Clin. Endocrinol. Metab. 94, 4216\u20134223 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-101-6-783","volume":"101","author":"A Warfield","year":"1984","unstructured":"A. Warfield, D.M. Finkel, N.J. Schatz, P.J. Savino, P.J. Snyder, Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function. Ann. Intern. Med. 101, 783\u2013785 (1984)","journal-title":"Ann. Intern. Med."},{"key":"1042_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2011.54","volume":"7","author":"JA Wass","year":"2011","unstructured":"J.A. Wass, R. Reddy, N. Karavitaki, The postoperative monitoring of nonfunctioning pituitary adenomas. Nat. Rev. Endocrinol. 7, 431\u2013434 (2011)","journal-title":"Nat. Rev. Endocrinol."},{"key":"1042_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1995.00430020067008","volume":"155","author":"LE Donovan","year":"1995","unstructured":"L.E. Donovan, B. Corenblum, The natural history of the pituitary incidentaloma. Arch. Intern. Med. 155, 181\u2013183 (1995)","journal-title":"Arch. Intern. Med."},{"key":"1042_CR30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cen.12860","volume":"83","author":"AH Sam","year":"2015","unstructured":"A.H. Sam, S. Shah, K. Saleh, J. Joshi, F. Roncaroli, S. Robinson, J. Cox, N.M. Martin, N. Mendoza, K. Meeran, A. Mehta, W.S. Dhillo, Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively. Clin. Endocrinol. (Oxf.) 83, 861\u2013865 (2015)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1042_CR31","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"A. Colao, G. Vitale, P. Cappabianca, F. Briganti, A. Ciccarelli, M. De Rosa, S. Zarrilli, G. Lombardi, Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J. Clin. Endocrinol. Metab. 89, 1704\u20131711 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11102-014-0563-z","volume":"18","author":"A Tirosh","year":"2015","unstructured":"A. Tirosh, C. Benbassat, A. Lifshitz, I. Shimon, Hypopituitarism patterns and prevalence among men with macroprolactinomas. Pituitary 18, 108\u2013115 (2015)","journal-title":"Pituitary"},{"key":"1042_CR33","first-page":"1789","volume":"85","author":"BM Arafah","year":"2000","unstructured":"B.M. Arafah, D. Prunty, J. Ybarra, M.L. Hlavin, W.R. Selman, The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J. Clin. Endocrinol. Metab. 85, 1789\u20131793 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR34","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"O.M. Dekkers, A.M. Pereira, J.A. Romijn, Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J. Clin. Endocrinol. Metab. 93, 3717\u20133726 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2004-820914","volume":"112","author":"M Wichers-Rother","year":"2004","unstructured":"M. Wichers-Rother, S. Hoven, R.A. Kristof, N. Bliesener, B. Stoffel-Wagner, Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp. Clin. Endocrinol. Diabetes 112, 323\u2013327 (2004)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"1042_CR36","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jcem-62-6-1173","volume":"62","author":"BM Arafah","year":"1986","unstructured":"B.M. Arafah, Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 62, 1173\u20131179 (1986)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1227\/01.NEU.0000325725.77132.90","volume":"63","author":"N Fatemi","year":"2008","unstructured":"N. Fatemi, J.R. Dusick, C. Mattozo, D.L. McArthur, P. Cohan, J. Boscardin, C. Wang, R.S. Swerdloff, D.F. Kelly, Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery 63, 709\u2013718 (2008)","journal-title":"Neurosurgery"},{"key":"1042_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ando.2015.04.004","volume":"76","author":"F Galland","year":"2015","unstructured":"F. Galland, M.C. Vantyghem, L. Cazabat, A. Boulin, F. Cotton, J.F. Bonneville, E. Jouanneau, G. Vidal-Trecan, P. Chanson, Management of nonfunctioning pituitary incidentaloma. Ann. Endocrinol. (Paris) 76, 191\u2013200 (2015)","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"1042_CR39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"A. Klibanski, Clinical practice. Prolactinomas. N. Engl. J. Med. 362, 1219\u20131226 (2010)","journal-title":"N. Engl. J. Med."},{"key":"1042_CR40","first-page":"145","volume":"7","author":"PF Day","year":"2005","unstructured":"P.F. Day, M. Guitelman, R. Artese, L. Fiszledjer, A. Chervin, N.M. Vitale, G. Stalldecker, V. Miguel, D. Cornal\u00f3, A. Alfieri, M. Susana, M. Gil, Retrospective multicentric study of pituitary incidentalomas. Pituitary 7, 145\u2013148 (2005)","journal-title":"Pituitary"},{"key":"1042_CR41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1480325","volume":"148","author":"A Colao","year":"2003","unstructured":"A. Colao, A.D. Sarno, P. Cappabianca, F. Briganti, R. Pivonello, C.D. Somma, A. Faggiano, B. Biondi, G. Lombardi, Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur. J. Endocrinol. 148, 325\u2013331 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"1042_CR42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4158\/EP13182.OR","volume":"20","author":"E Robenshtok","year":"2014","unstructured":"E. Robenshtok, C. Benbassat, D. Hirsch, G. Tzvetov, Z. Cohen, H. Iraqi, A. Gorshtein, Y. Toledano, I. Shimon, Clinical course and outcome of nonfunctioning pituitary adenomas in the elderly compared with younger age groups. Endocr. Pract. 20, 159\u2013164 (2014)","journal-title":"Endocr. Pract."},{"key":"1042_CR43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 364\u2013389 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1042_CR44","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","volume":"88","author":"FG Barker 2nd","year":"2003","unstructured":"F.G. Barker 2nd, A. Klibanski, B. Swearingen, Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J. Clin. Endocrinol. Metab. 88, 4709\u20134719 (2003)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1042-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:12:31Z","timestamp":1498317151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1042-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1042"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1042-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}